Prospect Capital Advisors’s CareDx CDNA Stock Holding History

Prospect Capital Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-51,150	Closed	-$1.16M	–	25
2019 Q3	$1.16M	Sell	51,150 -5,100	-9%	-$141K	0.59%	24
2019 Q2	$2.02M	Hold	56,250	–	–	0.86%	24
2019 Q1	$1.77M	Sell	56,250 -50	-0.1%	-$1.46K	0.91%	21
2018 Q4	$1.42M	Hold	56,300	–	–	0.84%	21
2018 Q3	$1.62M	Buy	56,300 +6,300	+13%	+$118K	0.79%	24
2018 Q2	$612K	Hold	50,000	–	–	0.28%	28
2018 Q1	$399K	Hold	50,000	–	–	0.23%	25
2017 Q4	$367K	Buy	+50,000	New	+$312K	0.23%	24

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Prospect Capital Advisors's CDNA Position: Q4 2019 in Review

Prospect Capital Advisors sold out of CareDx (CDNA) in Q4 2019, closing a stake of 51,150 shares — an estimated $1.16M sold.

Prospect Capital Advisors first reported a position in CDNA in Q4 2017 and held it in 8 quarters. The position peaked at $2.02M in Q2 2019. 159 funds tracked by Wall St. Rank hold CDNA as of Q4 2019.

Prospect Capital Advisors reported no remaining CareDx position as of Q4 2019 after selling out during the quarter.
Prospect Capital Advisors sold 51,150 CareDx shares in Q4 2019, an estimated $1.16M.
Prospect Capital Advisors first reported a position in CareDx in Q4 2017 and held it in 8 quarters.
Prospect Capital Advisors's CareDx position peaked at $2.02M in Q2 2019.
159 funds tracked by Wall St. Rank held CareDx as of Q4 2019.

Based on Prospect Capital Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.